Pharma Reviews: Indian pharma likely to report tepid earnings growth for Q3 FY17

The Indian pharmaceutical sector has seen a significant share of market value erode over the last couple of years owing to multiple challenges, most ...
Read more: Indian pharma likely to report tepid earnings growth for Q3 FY17